Ethical publishing: The innocent author's guide to avoiding misconduct

Menopause International

Volumn 13, Issue 3, 2007, Pages 98-102

  Wager, Elizabeth ^a  

^a NONE   (United Kingdom)

Author keywords

DUPLICATE PUBLICATIONS; PEER REVIEW; PLAGIARISM; PUBLICATION RETRACTIONS; SCIENTIFIC MISCONDUCT

Indexed keywords

ETHICS; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION DISSEMINATION; PEER REVIEW; PRACTICE GUIDELINE; PUBLICATION; PUBLISHING; RESEARCH ETHICS; REVIEW; SCIENTIFIC MISCONDUCT; CLINICAL RESEARCH; INFORMED CONSENT; PROFESSIONAL MISCONDUCT; WRITING;

ETHICS, RESEARCH; GUIDELINES AS TOPIC; HUMANS; INFORMATION DISSEMINATION; JOURNALISM; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; SCIENTIFIC MISCONDUCT; SOCIETIES, SCIENTIFIC;

EID: 38449117443     PISSN: 17540453     EISSN: None     Source Type: Journal    
DOI: 10.1258/175404507781605604     Document Type: Review

References (28)

1. Wade DT. Ethics, audit, and research: all shades of grey. BMJ 2005;330:468–71.
2. Wager E. Another year in the life of the BMJ's Ethics Committee, http://resources.bmj.com/bmj/about-bmj/ethics-committee/ethics-committee-annual-report-2005, last accessed June 2007.
3. Chalmers I, Lindley R. Double standards on informed consent to treatment. In: Doyal L, Tobias JS, eds. Informed Consent in Medical Research. London: BMJ Publications, 2000: 266–75.
4. Singer PA. Consent to the publication of patient information. BMJ 2004;329:566–8.
5. BMJ. Consent to publication, http://resources.bmj.com/bmj/about-bmj/ethics-committee/consent-to-publication, last accessed June 2007.
6. White C. Three journals raise doubts on validity of Canadian studies. BMJ 2004;328:67.
7. Moher D, Schulz KF, Altman DG, et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–4.
8. White C. Software makes it easier for journals to spot image manipulation. BMJ 2007;334:607.
9. Chan A-W, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials. JAMA 2004;291:2457–65.
10. Sim I, Chan A-W, Gülmezoglu AM, et al. Clinical trial registration: transparency is the watchword. Lancet 2006;367:1631–3.
11. Ricaurte GA, Yuan J, Hatzidimitriou G, et al. Retraction. Science 2003;301:1479.
12. Ricaurte GA, Yuan J, Hatzidimitriou G, et al. Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (‘ecstasy’). Science 2002;297:2260–3.
13. Wager E, Middleton P. Technical editing of research reports in biomedical journals (Cochrane Methodology Review). Cochrane Database Syst Rev 2007: MR000002.
14. Torgerson DJ, Adamson J, Cockayne S, et al. Submission to multiple journals: a method of reducing time to publication? BMJ 2005;330:305–7.
15. Tramèr MR, Reynolds DJM, Moore RA, et al. Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997;315:635–40.
16. Wager E. The need for trial identifiers. Curr Med Research Opinion 2004;20:203–6.
17. Committee on Publication Ethics. Case 02/04. In: COPE Report 2002. London: Committee on Publication Ethics, 2002.
18. ICMJE. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication, www.icmje.org/#author, last accessed June 2007.
19. Bhopal R, Rankin J, McColl E, et al. The vexed question of authorship: views of researchers in a British medical faculty. BMJ 1997;314:1009–12.
20. Dhaliwal U, Singh N, Bhatia A. Awareness of authorship criteria and conflict: survey in a medical institution in India. Medscape Gen Med 2006;8:52.
21. Marusic M, Bozicov J, Katavic V, et al. Authorship in a small medical journal: a study of contributorship statements by corresponding authors. Sci Eng Ethics 2004;10:493–502.
22. Pignatelli B, Maisonneuve H, Chapuis F. Authorship ignorance: views of researchers in French clinical settings. J Med Ethics 2005;31:578–81.
23. Gøtzsche P, Hrobjartsson A, Johansen HK, et al. Ghost authorship in industry-initiated randomised trials. PLoS Med 2007;4:e19.
24. Wager E, Field EA, Grossman L. Good Publication Practice for pharmaceutical companies. Curr Med Res Opin 2003;19:149–54.
25. Jacobs A, Wager E. EMWA guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21:317–21.
26. Albert T, Wager E. How to handle authorship disputes: a guide for new researchers. In: The COPE Report 2003. London: Committee on Publication Ethics, 2003.
27. Dyer O. Consultant struck off for fraudulent claims. BMJ 1995; 310:1554–5.
28. Rennie D. Misconduct and journal peer review. In: Godlee F, Jefferson T, eds. Peer Review in Health Sciences (2nd edition). London: BMJ Books, 2003: 118–29.